Actinium Pharmaceuticals's total assets for Q3 2025 were $56.15M, a decrease of -10.90% from the previous quarter. ATNM total liabilities were $42.37M for the fiscal quarter, a -3.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.